These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4596992)

  • 1. Prophylactic therapy of spontaneous leukemia in AKR mice by polyadenylic-polyuridylic acid.
    Drake WP; Cimino EF; Mardiney MR; Sutherland JC
    J Natl Cancer Inst; 1974 Mar; 52(3):941-4. PubMed ID: 4596992
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoprophylaxis and treatment of leukemia in AKR mice: repetitive use of BCG.
    Mardiney MR; Ungaro PC; Drake WP
    Natl Cancer Inst Monogr; 1973 Dec; 39():89-90. PubMed ID: 4595329
    [No Abstract]   [Full Text] [Related]  

  • 3. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 4. The dependence of successful immunotherapy on adequate tumor burden as shown by the treatment of AKR leukemia with poly A-poly U.
    Pendergrast WJ; Drake WP; Mardiney MR
    J Natl Cancer Inst; 1975 Nov; 55(5):1223-5. PubMed ID: 1206751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The age-dependent efficacy of polyadenylic-polyuridylic acid therapy upon the development of spontaneous leukemia in AKR mice.
    Drake WP; Pendergrast WJ; Kramer RE; Mardiney MR
    Cancer Res; 1976 Mar; 36(3):1172-5. PubMed ID: 1253174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 9. Discussion paper: effect of hemolytic streptococci on lymphocytic leukemia in AKR mice.
    Havas HF
    Ann N Y Acad Sci; 1976; 277(00):299-301. PubMed ID: 1069550
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of three strains of BCG against a murine leukemia after drug therapy.
    Sher NA; Pearson JW; Chaparas SD; Chirigos MA
    J Natl Cancer Inst; 1973 Dec; 51(6):2001-3. PubMed ID: 4587756
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
    Youn JK; Lacour F; Hue G
    Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of BCG and other bacteria against neoplasia in mice and hamsters.
    Lemonde P
    Natl Cancer Inst Monogr; 1973 Dec; 39():21-32. PubMed ID: 4362522
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined drug and immunostimulation therapy against a syngeneic murine leukemia.
    Pearson JW; Chirigos MA; Chaparas SD; Sher NA
    J Natl Cancer Inst; 1974 Feb; 52(2):463-8. PubMed ID: 4593139
    [No Abstract]   [Full Text] [Related]  

  • 14. Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice.
    Ungaro PC; Drake WP; Mardiney MR
    J Natl Cancer Inst; 1973 Jan; 50(1):125-8. PubMed ID: 4692859
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapy.
    Drake WP; Pendergrast WJ; Kramer RE; Mardiney MR
    Cancer Res; 1975 Nov; 35(11 Pt 1):3051-3. PubMed ID: 1182699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active immunotherapy of AkR mice spontaneous leukemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Rev Eur Etud Clin Biol; 1972 Dec; 17(10):997-1000. PubMed ID: 4660002
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic activity of pretazettine, a narcissus alkaloid, on spontaneous AKR leukemia.
    Furusawa E; Lockwood RH; Furusawa S; Lum MK; Lee JY
    Chemotherapy; 1979; 25(5):308-15. PubMed ID: 225136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive cells in cancer-active immunotherapy: their cytotoxic potential and genetic restriction.
    Olsson L; Kiger N; Mathe G
    Transplant Proc; 1980 Mar; 12(1):167-71. PubMed ID: 7368287
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of B.C.G. on the hepatic catalase activity in mouse. Relation between the reticuloendothelial system and the resistance against grafted AKR leukemia].
    Lamensans A; Mollier MF; Laurent M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):871-6. PubMed ID: 4885127
    [No Abstract]   [Full Text] [Related]  

  • 20. [BCG and experimental leukemia].
    Amiel JL; Berardet M
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.